Radiopharm Theranostics Ltd Share Price (NASDAQ: RADX)

Radiopharm Theranostics Ltd Stock Performance

as on October 15, 2025 at 1:25 am IST

Day's Low
Day's High
$6.8
Day's Price Range
$7.44
$7.2
5.56%
Downside
3.33%
Upside
52 Week's Low
52 Week's High
$3.5
52-Week Price Range
$50.82
$7.2
51.44%
Downside
605.83%
Upside

Radiopharm Theranostics Ltd share price movements today

Previous Close: $7.10
Open: $7.09
Volume: 544.6K
Day's Low - High: $6.8 - $7.44
52 Week Low - High: $3.5 - $50.82

Radiopharm Theranostics Ltd Historical Returns

1 Month Return: + 5.33 %
3 Month Return: + 68.41 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Radiopharm Theranostics Ltd Stock Fundamentals & Key Indicators

Check Radiopharm Theranostics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$55.2M

EPS (TTM)

-0.023

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

144109400.00%

Radiopharm Theranostics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Radiopharm Theranostics Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Radiopharm Theranostics Ltd	NA	$55.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	226.08%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.1B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.4B	91.48%	28.99	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.1B	-2.15%	14.07	31.37%

Radiopharm Theranostics Ltd Stock’s Investor Sentiment and Interest

Search interest for Radiopharm Theranostics Ltd Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 16, 2025 to October 16, 2025

Change:-46% versus previous 30 day period

Radiopharm Theranostics Ltd Annual Profit & Loss

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	0	0	0	3
Gross Profit	0	0	0	0
Operating Income	-19	-34	-36	-38
EBITDA	-17	-31	-44	-38
Interest Expense	9	0	0	0
Depreciation	2	3	3	0
Income Before Tax	-30	-34	-47	-38
Income Tax Expense	0	0	0	0
Net Income	-21	-23	-31	-38
Net Profit Margin	-343550.89%	-11838.59%	-16024.28%	-1055.27%

Radiopharm Theranostics Ltd Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Net Income	-	-	-	-
Operating Cash Flow	-4	-7	-13	-8
Investing Cash Flow	-	-	2	0
Financing Cash Flow	5	22	38	-2
Change in Cash	1	15	27	-9

Radiopharm Theranostics Ltd Annual Cash Flow

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-30	-34	-47	-38
Operating Cash Flow	-9	-23	-22	-36
Investing Cash Flow	-28	-1	0	1
Financing Cash Flow	65	9	30	45
Change in Cash	26	-15	6	10

Insights on Radiopharm Theranostics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, RADX stock has moved up by 68.4%

About Radiopharm Theranostics Ltd

Radiopharm Theranostics Limited is an Australia-based clinical-stage company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. It has a pipeline of differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development from some of the universities and institutes around the world. The clinical program includes one Phase II and two Phase I trials in a variety of solid tumor cancers including lung, pancreas and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, DUNP19 and PTPu. Nano-mAbs is a radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate that utilizes the early steps of fatty acid oxidation.

Organisation	Radiopharm Theranostics Ltd
Headquarters	62 Lygon Street, Carlton, VIC, Australia, 3053
CEO	Mr. Riccardo Canevari
E-voting on shares	Click here to vote

Key Management of Radiopharm Theranostics Ltd

Name	Title
Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD	Founder & Executive Chairman
Mr. Riccardo Canevari	MD, CEO & Director
Mr. Phillip Hains	CFO, Joint Company Secretary & Executive Director
Dr. Dimitris Voliotis M.D.	Chief Medical Officer
Mr. Hitesh Goel	Head of Project Management
Mr. Nathan Jong C.A.	Joint Company Secretary

FAQs

What is Radiopharm Theranostics Ltd share price today?

Radiopharm Theranostics Ltd share price today is $7.2 as on October 15, 2025 at 1:25 am IST. Radiopharm Theranostics Ltd share today touched a day high of $7.44 and a low of $6.8.

What is the 52 week high and 52 week low for Radiopharm Theranostics Ltd share?

Radiopharm Theranostics Ltd share touched a 52 week high of $50.82 on December 6, 2024 and a 52 week low of $3.5 on April 7, 2025. Radiopharm Theranostics Ltd stock price today i.e. October 15, 2025 at 1:25 am IST is trending at $7.2,which is 85.83% down from its 52 week high and 105.94% up from its 52 week low.

What is Radiopharm Theranostics Ltd's market capitalisation today?

Radiopharm Theranostics Ltd market capitalisation is $0.00T as on October 15, 2025 at 1:25 am IST.

How to invest in Radiopharm Theranostics Ltd Stock (RADX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Radiopharm Theranostics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Radiopharm Theranostics Ltd Shares that will get you 0.2083 shares as per Radiopharm Theranostics Ltd share price of $7.2 per share as on October 15, 2025 at 1:25 am IST.

What is the minimum amount required to buy Radiopharm Theranostics Ltd Stock (RADX) from India?

Indian investors can start investing in Radiopharm Theranostics Ltd (RADX) shares with as little as ₹87.985 or $1 (as of October 16, 2025 at 12:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Radiopharm Theranostics Ltd stock (as per the Rupee-Dollar exchange rate as on October 16, 2025 at 12:41 am IST). Based on Radiopharm Theranostics Ltd share’s latest price of $7.2 as on October 15, 2025 at 1:25 am IST, you will get 1.3889 shares of Radiopharm Theranostics Ltd. Learn more about fractional shares .